Protagen, German Cancer Center Collaborate on Immunotherapy Biomarkers – GenomeWeb
|
Protagen, German Cancer Center Collaborate on Immunotherapy Biomarkers
GenomeWeb NEW YORK (GenomeWeb) – Protagen said today that it is collaborating with the German National Center for Tumor Diseases (NCT) Heidelberg to identify biomarkers for predicting response to immunotherapy in melanoma patients. The work will use … |
